Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)
China · Delayed Price · Currency is CNY 100.08
+1.11 (1.12%)
Aug 14, 2026, 3:00 PM CST
SHA:688131 Market Cap
SHA:688131 has a market cap or net worth of 21.34 billion as of August 14, 2026. Its market cap has increased by 83.34% in one year.
Market Cap
21.34B
Enterprise Value
22.08B
Revenue
3.00B
Ranking
n/a
PE Ratio
87.01
Stock Price
100.08
ChartMarket Cap Chart
Since June 8, 2021, SHA:688131's market cap has decreased from 23.30B to 21.34B, a decrease of -8.41%. That is a compound annual growth rate of -1.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 21.34B | 39.59% |
| Dec 31, 2025 | 15.29B | 103.03% |
| Dec 31, 2024 | 7.53B | -3.82% |
| Dec 29, 2023 | 7.83B | -32.18% |
| Dec 30, 2022 | 11.54B | -37.56% |
| Dec 31, 2021 | 18.49B | -20.66% |
| Jun 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 24.19B |
| Guangdong Zhongsheng Pharmaceutical | 23.33B |
| Tasly Pharmaceutical Group | 22.90B |
| Hybio Pharmaceutical | 22.84B |
| Hubei Jumpcan Pharmaceutical | 22.59B |
| Harbin Pharmaceutical Group | 22.44B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.31B |
| Walvax Biotechnology | 21.24B |